Skip to content

The Effect of Light Deprivation on Visual Functions in Adult Amblyopes

The Effect of Light Deprivation on Visual Functions in Adult Amblyopes

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02799836
Enrollment
0
Registered
2016-06-15
Start date
2019-08-01
Completion date
2020-06-01
Last updated
2020-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amblyopia, Anisometropia, Visual Impairment

Brief summary

Amblyopia is a significant health problem, affecting up to 4% of the population in the United States. Amblyopia, commonly known as lazy eye, is a developmental visual disorder in which one or both eyes suffer from poor vision as a result of being disadvantaged in early life. Strabismus, or eye misalignment, such as crossed eyes (esotropia) or wandering eyes (exotropia), and anisometropia, or a power difference between the eyes, are the most common causes of amblyopia. If conventional treatment, such as patching the better seeing eye, is not initiated during the critical period of visual development, lasting visual impairment may persist throughout life. This critical period of visual development has been thought to end around age 10. However, recent research has demonstrated that the critical period of visual development can be extended into adulthood. Complete light deprivation in animal models has restored plasticity in the visual cortex and has demonstrated drastic recovery of vision in amblyopic eyes. The objective of this pilot study is to evaluate the impact of complete light deprivation on visual function in a cohort of human adults with severe amblyopia from anisometropia.

Interventions

DEVICEBlindfold

Study subjects will be blindfolded to create an environment of complete light deprivation which will be worn for 48 hours.

Sponsors

Boston Children's Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Amblyopia, defined as decreased vision, less than or equal to 20/100, in one eye secondary to anisometropia * Age 18-50 years

Exclusion criteria

* Strabismus * Eye pathology, such as cataract, corneal disorder, maculopathy, glaucoma, * Mental health diagnosis, such as depression, schizophrenia, bipolar disorder or anxiety disorder

Design outcomes

Primary

MeasureTime frame
Logmar visual acuityMeasured at 60 minutes after blindfold is removed

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026